RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Biotherapies in cardiovascular disease: from bench to bedside Biotherapies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by